A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine.

Vanderbilt investigators report that dysregulation of certain immune cells in the intestines may lead to inflammation and disease.

Infectious diseases specialist David Aronoff, M.D., recently became one of 73 new fellows of the American Academy of Microbiology, an honorific leadership group within the American Society of Microbiology.

Among the thousands of scientists and their supporters who participated in Saturday’s March for Science in Nashville and in Washington, D.C., were several faculty members from Vanderbilt University Medical Center and Vanderbilt University.

Pathologist Carol Rauch, M.D., Ph.D., likes being prepared.

James Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, is the 2017 recipient of the Stanley J. Korsmeyer Award given by the American Society for Clinical Investigation (ASCI), one of the nation’s oldest and most respected honor societies for physician-scientists.